Literature DB >> 11442597

Longitudinal melanonychia.

E Haneke1, R Baran.   

Abstract

BACKGROUND: Ungual melanoma is the most serious disease affecting the nail. The majority start with a longitudinal brown streak in the nail.
OBJECTIVE: To outline the different nail pigmentations, their differential diagnoses, treatment, and prognosis.
METHOD: Clinical and histologic evaluation of dark nail pigmentations.
CONCLUSION: Brown to black nail pigmentation may be due to different coloring substances of exogenous and endogenous origin. Exogenous pigmentations usually are not streaky or do not present as a stripe of even width with regular borders. Bacterial pigmentation, most commonly due to Pseudomonas aeruginosa or Proteus spp., have a greenish or grayish hue and the discoloration is often confined to the lateral edge of the nail. Subungual hematoma may result from a single heavy trauma or repeated microtrauma which often escapes notice. The latter is usually found on the medial aspect of the great toe. Although oval in shape, it commonly does not form a neat streak. Melanin pigmentation in the form of a longitudinal streak in the nail is due to a pigment-producing focus of melanocytes in the matrix. Neither the color intensity nor the age of the patient are proof of benignity or malignancy although subungual melanomas are very rare in children and malignant longitudinal melanonychia is usually wider than 5 mm. Hutchinson's melanotic whitlow, nail dystrophy, and a bleeding mass strongly suggest malignancy. Treatment is as conservative as possible in order to keep the tip of the digit; once the melanoma is completely removed, amputations have not been shown to prolong the disease-free survival time.

Entities:  

Mesh:

Year:  2001        PMID: 11442597

Source DB:  PubMed          Journal:  Dermatol Surg        ISSN: 1076-0512            Impact factor:   3.398


  15 in total

1.  Longitudinal melanonychia.

Authors:  Kamran Khan; Arun A Mavanur
Journal:  BMJ Case Rep       Date:  2015-12-10

2.  Delayed Reconstruction for the Non-Amputative Treatment of Subungual Melanoma.

Authors:  Byung Ho Oh; Hong Sun Jang; Jungsoo Lee; Min Ju Choi; Kyoung Ae Nam; Kee Yang Chung
Journal:  Ann Dermatol       Date:  2015-07-29       Impact factor: 1.444

3.  Cyclophosphamide and Doxorubicin Induced Melanonychia: A Case Report.

Authors:  Vivek Bhanubhai Prajapati; Sharath Madhyastha; Raviraj Acharya; Vinaya Gopalaswamy; Akhila Doddamani
Journal:  J Clin Diagn Res       Date:  2017-01-01

Review 4.  [Dark nail: clinical findings, diagnostics and therapy of melanonychia].

Authors:  C Löser; P A Mayser
Journal:  Hautarzt       Date:  2014-04       Impact factor: 0.751

5.  A survey-based study of management of longitudinal melanonychia amongst attending and resident dermatologists.

Authors:  Pierre Halteh; Richard Scher; Amanda Artis; Shari R Lipner
Journal:  J Am Acad Dermatol       Date:  2017-05       Impact factor: 11.527

6.  Assessment of Patient Knowledge of Longitudinal Melanonychia: A Survey Study of Patients in Outpatient Clinics.

Authors:  Pierre Halteh; Richard Scher; Amanda Artis; Shari Lipner
Journal:  Skin Appendage Disord       Date:  2016-11-09

7.  Subungual Nail Erythrasma Presenting as Melanonychia: A Rare Finding.

Authors:  Jalal Maghfour; Jennifer Kane; Leslie Robinson-Bostom; John Kawaoka; Nathaniel Jellinek
Journal:  Skin Appendage Disord       Date:  2020-10-05

8.  Tangential Biopsy Thickness versus Lesion Depth in Longitudinal Melanonychia: A Pilot Study.

Authors:  Nilton Di Chiacchio; Walter Refkalefsky Loureiro; Nilceo Schwery Michalany; Felipe Veiga Kezam Gabriel
Journal:  Dermatol Res Pract       Date:  2012-03-14

9.  Advanced nail surgery.

Authors:  Eckart Haneke
Journal:  J Cutan Aesthet Surg       Date:  2011-09

Review 10.  Laugier-Hunziker syndrome: a report of three cases and literature review.

Authors:  Wen-Mei Wang; Xiang Wang; Ning Duan; Hong-Liu Jiang; Xiao-Feng Huang
Journal:  Int J Oral Sci       Date:  2012-11-23       Impact factor: 6.344

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.